Generative AI is being used at home, school, and in hospitals. So what do pediatricians need to know so they can guide patients and families on safe usage of AI? In this episode, Stephon N. Proctor, PhD, ABPP and Daria F. Ferro, MD, share insights from their research on the implications of generative AI For families and pediatricians and explore how pediatricians can mitigate negative effects of this technology.

This episode qualifies for AMA PRA Category 1 Credits™. Visit chop.cloud-cme.com and search for the episode title to claim credit.

Do all children need a pediatrician visit after bronchiolitis hospitalization? Not necessarily. Join host Katie Lockwood, MD, MEd and Christopher Bonafide, MD, MSCE, as they discuss the evidence behind as-needed follow-up, reducing unnecessary healthcare visits, empowering families, and the exciting work of the I-DECIDE study to bring evidence-based care into everyday practice.

This episode qualifies for AMA PRA Category 1 Credits™. Visit chop.cloud-cme.com and search for the episode title to claim credit.

We’re joined by Juhee Lee, MD, to discuss de-labeling drug allergies and why reassessing reported allergies can be an important part of improving patient care. Dr. Lee shares practical insights for primary care clinicians on evaluating drug allergy histories and identifying patients who may safely benefit from de-labeling. Why is de-labeling important? It can improve care, lower costs, and slow antimicrobial resistance.

National Penicillin Allergy Day is September 28th, marking the anniversary of Sir Alexander Fleming's discovery of penicillin in 1928!

For more information, visit: Drug Reaction Evaluation and Management Program | Children's Hospital of Philadelphia